New research published in the Journal of Bone and Mineral Research has found that cognitive decline is linked with accelerated bone loss and an increased fracture risk in women.
In the study of 1,741 women and 620 men aged ≥65 years without dementia who were followed from 1997 through 2013, both genders experienced similar declines in cognitive function and bone mass.
After adjustments, cognitive decline was associated with bone loss in women but not men. Also, significant and clinical important cognitive decline in women was associated with a 1.7-fold higher risk of bone fractures over the subsequent 10 years.
Notably, the relationship between bone loss and cognitive decline was bidirectional with no evidence of one preceding the other. The relationship between cognitive decline, bone loss, and fracture risk in women may be driven by shared risk factors.
“These findings may help refine clinical practices guidelines regarding how bone loss and cognitive decline can be monitored in older age, to ensure appropriate and effective treatment,” said lead author Dana Bliuc, PhD, MD, of the Garvan Institute of Medical Research, in Australia. “This is particularly important because both bone loss and cognitive decline are ‘silent conditions’ that can go undetected for long periods of time, often until the conditions have severely progressed.”
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/jbmr.4402
About Journal
The Journal of Bone and Mineral Research (JBMR) publishes highly impactful original manuscripts, reviews, and special articles on basic, translational and clinical investigations relevant to the musculoskeletal system and mineral metabolism. Specifically, the journal is interested in original research on the biology and physiology of skeletal tissues, interdisciplinary research spanning the musculoskeletal and other systems, including but not limited to immunology, hematology, energy metabolism, cancer biology, and neurology, and systems biology topics using large scale “-omics” approaches. The journal welcomes clinical research on the pathophysiology, treatment and prevention of osteoporosis and fractures, as well as sarcopenia, disorders of bone and mineral metabolism, and rare or genetically determined bone diseases.
About Wiley
Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.